BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Cell Therapy
    • COVID-19
    • CAR-T
    • Cord Blood
  • Exosomes
  • Interviews
  • News
    • Press Releases
    • Job Posts
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Stem Cells » Adipose SCs » Page 3

Future of Regenerative Medicine with Kyle Cetrulo of AuxoCell

April 26, 2017 By Cade Hildreth (CEO)

Future of Regenerative Medicine Congress

I had the honor of interviewing Kyle Cetrulo, CEO of AuxoCell Laboratories. In this interview, we explore the upcoming Future of Regenerative Medicine Congress, as well as future directions for regenerative medicine at large. Enjoy.  [Read more…]

Filed Under: Adipose SCs, HSCs, MSCs, Stem Cells Tagged With: Auxocell, conference, regenerative medicine

Stem Cell Research Products | Market Size, Segments, & Trends

February 19, 2017 By Cade Hildreth (CEO)

stem cells size | “Stem Cell Research Products – Opportunities, Tools, & Technologies” – Market Size, Segments, & Trends

“Stem Cell Research Products – Opportunities, Tools, & Technologies” is a global strategic report that evaluates opportunities across the entire stem cell product spectrum with an emphasis on opportunities for research product development.

Stem Cells Size | A Stem Cell Business Opportunity

In this article:

  • About The Global Strategic Report
  • Broad Categories Of Stem Cells
  • Stem Cell Research and Its Commercial Interest
  • Areas of Stem Cell Research
  • Big Companies in Stem Cell Research Products and Key Report Findings

[Read more…]

Filed Under: Adipose SCs, HSCs, iPS Cells, MSCs, Neural Stem Cells, Stem Cells

Okyanos – Adipose-Derived Stem Cell Treatments with CEO Matt Feshbach

November 15, 2016 By Cade Hildreth (CEO)

Matthew Feshbach, CEO and Co-Founder of Okyanos
Matthew Feshbach, CEO and Co-Founder of Okyanos

Founded in 2011, Okyanos (pronounced “Oh – key – AH – nos”) is an innovative stem cell therapy provider that specializes in treating patients with congestive heart failure (CHF) and other chronic conditions. The literary name Okyanos, the Greek God of the river Okyanos, symbolizes the restoration of blood flow. Okyanos Cell Therapy delivers a mixed population of fat (adipose) derived stem and regenerative cells (ADRCs) using internationally-approved technology to patients with chronic, degenerative conditions.  Okyanos is fully licensed under the Bahamas Stem Cell Therapy and Research Act and adheres to U.S. surgical center standards.  [Read more…]

Filed Under: Adipose SCs, Interviews, MSCs, Stem Cells Tagged With: adipose, cell therapy, interview, Okyanos

Current Landscape for Stem Cell Clinical Trials

November 11, 2016 By Cade Hildreth (CEO)

Landscape for Stem Cell Clinical Trials

To understand the growing market potential for stem cell therapies, it is critical to consider the current landscape for stem cell clinical trials.

ClinicalTrials.govThere are 5561 clinical trials found when the term “stem cells” is searched on ClinicalTrials.gov, indicating that there are now thousands of stem cell trials underway worldwide. (Search executed November 7, 2016.)

ClinicalTrials.gov is the global registry of publicly and privately supported clinical studies involving human patients. While not a comprehensive resource, it contains approximately three-quarters of registered cell therapy trials worldwide.

Below is a map showing the location of current stem cell clinical trials.

Map of Stem Cell Clinical Trials, by Geographical Region

Map of Stem Cell Clinical Trials

“Hotspots” for Stem Cell Clinical Trial Activity

Clearly, North America (3057 trials) and Europe (1288 trials) are “hotspots” for stem cell clinical trial activity.

Among the North American trials, nearly all of them of them are occurring in the United States (2935).  [Read more…]

Filed Under: Adipose SCs, HSCs, iPS Cells, MSCs, Stem Cell News, Stem Cells Tagged With: clinical trial, mesenchymal stem cells

Boston Biolife to Host Stem Cell and Regenerative Medicine Workshops in Dallas, San Diego, and Washington, DC

October 10, 2016 By Cade Hildreth (CEO)

Boston Biolife - Courses and Workshops

Boston BiolifeBoston BioLife (www.bostonbiolife.com) is a cutting-edge organization that provides workshops for physicians and scientists interested in learning regenerative medicine. Its mission is to facilitate the introduction of emerging life sciences technologies to scientists and healthcare providers. [Read more…]

Filed Under: Adipose SCs, HSCs, MSCs, Stem Cells Tagged With: Boston Biolife, regenerative medicine, workshop

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 10
  • Next Page »

Let’s Get Social

  • Facebook
  • Twitter
  • Instagram
  • Pinterest
  • LinkedIn

Nanocellect

Marathon Products

Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • US Cord Blood and Cord Tissue Storage Rates Rates of U.S. Cord Blood and Cord Tissue Storage - Historical and Projected
    Evaluat la 0 din 5
    $197
  • Job Posting on BioInformant Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience
    Evaluat la 0 din 5
    $297
  • BioInformant Audience Reach BioInformant's Audience with Your Press Announcement
    Evaluat la 0 din 5
    $397 $297

Featured Posts

Stem cell conferences

The Complete Guide To Virtual Stem Cell Conferences in 2021

CO.DON AG

The New CO.DON Plant for the EU-approved Advanced Therapy Cartilage Regeneration Treatment Sets a Milestone in Cell Therapy for Commercial Manufacturing

Safety Chart | The Future of Stem Cell Therapeutics – Balancing Safety and Efficacy

The Future of Stem Cell Therapeutics – Balancing Safety and Efficacy

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2021 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.